Recent work has demonstrated that aromatase protein and BDE2 levels are upregulated in response to brain insults such as GCI and brain trauma and that BDE2 exerts anti-inflammatory/neuroprotective effects [11,19,21]. This evidence concerns the gene CYP19A1 and brain injury.